Industry Payments to Doctors Tied to Nonrecommended, Low-Value Drug Use
FRIDAY, Oct. 27, 2023 (HealthDay News) — Industry payments to physicians are associated with...
Read More
Hematology/Oncology
ACG: Digital Risk Assessment Tool Can ID Risk for Cancer Susceptibility Syndromes
THURSDAY, Oct. 26, 2023 (HealthDay News) — Implementation of a digital risk assessment tool...
Read More
Affording Health Care Now a Struggle for Half of Americans: Poll
THURSDAY, Oct. 26, 2023 (HealthDay News) — More than half of working-age Americans struggle...
Read More
ESMO: Pembrolizumab + Chemo, Trastuzumab Beneficial in Gastroesophageal Cancer
WEDNESDAY, Oct. 25, 2023 (HealthDay News) — For patients with HER2-positive gastroesophageal...
Read More
Racial, Ethnic Differences ID’d for Idecabtagene Vicleucel in Multiple Myeloma
WEDNESDAY, Oct. 25, 2023 (HealthDay News) — There are some racial and ethnic differences in...
Read More
Health Care Workers Reported More Days of Poor Mental Health in 2022
WEDNESDAY, Oct. 25, 2023 (HealthDay News) — Health workers continued to report poor mental...
Read More
Atezolizumab Added to Chemo and PARP Inhibitor Shows No Benefit in Recurrent Ovarian Cancer
Atezolizumab plus chemotherapy and maintenance niraparib in late-relapsing recurrent chemotherapy-sensitive ovarian cancer does not significantly improve outcomes.
Read More
ACG: Noninvasive Multitarget Stool RNA Test Has High Sensitivity for CRC
TUESDAY, Oct. 24, 2023 (HealthDay News) — A noninvasive, multitarget stool RNA (mt-sRNA)...
Read More
Exposure to PFAS Linked to Increased Rate of Thyroid Cancer
TUESDAY, Oct. 24, 2023 (HealthDay News) — Exposure to per- and polyfluoroalkyl substances...
Read More
EPA to Ban Carcinogenic Chemical Found in Degreasers, Cleaners
TUESDAY, Oct. 24, 2023 (HealthDay News) — The U.S. Environmental Protection Agency (EPA)...
Read More
CRC Screening Uptake No Better With Use of FIT in At-Risk Individuals
TUESDAY, Oct. 24, 2023 (HealthDay News) — For first-degree relatives of patients with...
Read More
Survival Improved With Everolimus in High-Risk Clear Cell Renal Cancer
MONDAY, Oct. 23, 2023 (HealthDay News) — For patients with clear cell renal cell carcinoma...
Read More
Diabetes Severity Tied to Outcome in CRC Patients Undergoing Resection
MONDAY, Oct. 23, 2023 (HealthDay News) — The severity of diabetes is associated with...
Read More
Georgia to Be First State to Let Pharmacies Sell Low-Dose Cannabis
MONDAY, Oct. 23, 2023 (HealthDay News) — Four years after the state of Georgia approved the...
Read More
Cell-Free DNA Methylation Liquid Biopsy Discriminates Ovarian Cancer
THURSDAY, Oct. 19, 2023 (HealthDay News) — A classifier based on cell-free DNA (cfDNA)...
Read More
2008 to 2020 Saw Increase in Survival for Advanced Prostate Cancer
THURSDAY, Oct. 19, 2023 (HealthDay News) — During a time period with improvements in...
Read More
Induced Abortion in First Trimester Not Linked to Rh Sensitization
THURSDAY, Oct. 19, 2023 (HealthDay News) — Induced first-trimester abortion is not...
Read More
Amazon to Test Drones to Deliver Prescriptions Directly to Patient Homes
THURSDAY, Oct. 19, 2023 (HealthDay News) — Amazon announced Wednesday that it has started to...
Read More
More Serious Adverse Events Seen With Debulking + Systemic Therapy in Metastatic CRC
FRIDAY, Oct. 20, 2023 (HealthDay News) — For patients with multiorgan metastatic colorectal...
Read More
Tolerable Treatments Lacking for Higher-Risk Myelodysplastic Syndromes
FRIDAY, Oct. 20, 2023 (HealthDay News) — There is a clear, unmet need for tolerable...
Read More